Frankfurt - Delayed Quote EUR
AC Immune SA (IMR.F)
1.3940
-0.0180
(-1.27%)
At close: May 2 at 8:20:09 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
46,002
65,842
-60,408
-73,568
-65,689
Investing Cash Flow
-78,701
-105,290
65,645
23,763
-53,664
Financing Cash Flow
-690
-1,120
43,250
-1,346
40,746
End Cash Position
23,620
36,275
78,494
31,586
82,216
Capital Expenditure
-689
-576
-801
-1,239
-2,635
Issuance of Capital Stock
4,345
111
43,798
7
17,802
Issuance of Debt
--
--
--
--
23,463
Repayment of Debt
-769
-683
-548
-569
-513
Repurchase of Capital Stock
--
--
--
-8
--
Free Cash Flow
45,313
65,266
-61,209
-74,807
-68,324
12/31/2021 - 10/6/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7SS.MU Brii Biosciences Ltd
0.2220
+2.78%
473A.SG Adaptimmune Therapeutics PLC
0.2440
+1.67%
41X.MU Ardelyx Inc
3.6740
-23.41%
22UA.HM BioNTech SE
92.50
+2.83%
MDG1.DE Medigene AG
0.1335
-27.64%
OCS Oculis Holding AG
18.87
+6.43%
REVB Revelation Biosciences, Inc.
2.8600
-4.03%
22UA.DE BioNTech SE
92.60
+1.54%
DRMA Dermata Therapeutics, Inc.
0.8699
+5.90%
ACET Adicet Bio, Inc.
0.6700
+6.60%